Jf. Lambert et al., THE 3' HALF OF THE MOUSE MAMMARY-TUMOR VIRUS ORF GENE IS NOT SUFFICIENT FOR ITS SUPERANTIGEN FUNCTION IN TRANSGENIC MICE, Molecular immunology, 30(16), 1993, pp. 1399-1404
The Mouse Mammary Tumor Virus (MMTV) long terminal repeat contains an
open reading frame (orf) of 960 nucleotides encoding a 36 kDa polypept
ide with a putative transmembrane domain and five N-glycosylation site
s in the N-terminal part of the protein. Transgenic mice bearing eithe
r the complete or the 3' terminal half of the orf sequence of MMTV-GR
under the control of the SV40 promoter were raised. As shown previousl
y by FACS analysis transgenic mice which express the complete orf gene
have a significant deletion of Vbeta14 expressing T cells at 6 weeks
of age. Here we show that no clonal deletion of Vbeta14 bearing T cell
s takes place in transgenic mice that contain orf sequences from the f
ifth ATG to the termination codon. The pattern of tissues expressing t
he truncated transgene was studied by the Polymerase Chain Reaction (P
CR) and was very similar to the one obtained in the Vbeta14 deleting a
nimals. These data suggest that the amino-terminal portion of the ORF
protein (pORF) is required for a superantigen function, while our prev
ious data indicated that determinants from the carboxy-terminus play a
n important role for TCR Vbeta specificity.